Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy

被引:28
作者
McInnes, Fiona J.
O'Mahony, Bridget
Lindsay, Blythe
Band, Janet
Wilson, Cliue G.
Hodges, Lee Ann
Stevens, Howard N. E.
机构
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland
[2] Bioimages Res Ltd, Glasgow, Lanark, Scotland
关键词
nasal residence; gamma scintigraphy; bioadhesion; nasal administration; lyophilisation; HPMC;
D O I
10.1016/j.ejps.2007.02.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioadhesive dosage forms are a potential method for overcoming rapid mucociliary transport in the nose. A lyophilised nasal insert formulation previously investigated in sheep demonstrated prolonged absorption of nicotine hydrogen tartrate suggestive of extended nasal residence, and increased bioavailability The current study was performed to quantify nasal residence of the formulations using gamma scintigraphy, and to investigate the absorption of a larger molecule, namely insulin. A four-way crossover study was conducted in six healthy male volunteers, comparing a conventional nasal spray solution with three lyophilised nasal insert formulations (1-3% hydroxypropylmethylcellulose (HPMC)). The conventional nasal spray deposited in the posterior nasal cavity in only one instance, with a rapid clearance half-life of 9.2 min. The nasal insert formulations did not enhance nasal absorption of insulin, however an extended nasal residence time of 4-5 h was observed for the 2% HPMC formulation. The 1% HPMC insert initially showed good spreading behaviour; however, clearance was faster than for the 2% formulation. The 3% HPMC nasal insert showed no spreading, and was usually cleared intact from the nasal cavity within 90 min. in conclusion, the 2% HPMC lyophilised insert formulation achieved extended nasal residence, demonstrating an optimum combination of rapid adhesion without over hydration. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 23 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine
    Bryant, ML
    Brown, P
    Gurevich, N
    McDougall, IR
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (02) : 171 - 174
  • [3] Tissue distribution of radioactivity following intranasal administration of radioactive microspheres
    Eyles, JE
    Spiers, ID
    Williamson, ED
    Alpar, HO
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (05) : 601 - 607
  • [4] THE INFLUENCE OF INSULIN AND SOME EXCIPIENTS USED IN NASAL INSULIN PREPARATIONS ON MUCOCILIARY CLEARANCE
    GIZURARSON, S
    MARRIOTT, C
    MARTIN, GP
    BECHGAARD, E
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (03) : 243 - 247
  • [5] GUIDA DD, 2000, CLIN NUCL MED, V25, P127
  • [6] EFFECT OF VISCOSITY ON PARTICLE-SIZE, DEPOSITION, AND CLEARANCE OF NASAL DELIVERY SYSTEMS CONTAINING DESMOPRESSIN
    HARRIS, AS
    SVENSSON, E
    WAGNER, ZG
    LETHAGEN, S
    NILSSON, IM
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) : 405 - 408
  • [7] INVESTIGATION OF THE NASAL ABSORPTION OF BIOSYNTHETIC HUMAN GROWTH-HORMONE IN SHEEP - USE OF A BIOADHESIVE MICROSPHERE DELIVERY SYSTEM
    ILLUM, L
    FARRAJ, NF
    DAVIS, SS
    JOHANSEN, BR
    OHAGAN, DT
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (03) : 207 - 211
  • [8] BIOADHESIVE MICROSPHERES AS A POTENTIAL NASAL DRUG DELIVERY SYSTEM
    ILLUM, L
    JORGENSEN, H
    BISGAARD, H
    KROGSGAARD, O
    ROSSING, N
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (03) : 189 - 199
  • [9] EFFECTS OF SODIUM TAURODIHYDROFUSIDATE ON NASAL ABSORPTION OF INSULIN IN SHEEP
    LONGENECKER, JP
    MOSES, AC
    FLIER, JS
    SILVER, RD
    CAREY, MC
    DUBOVI, EJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (05) : 351 - 355
  • [10] Nasal mucociliary clearance as a factor in nasal drug delivery
    Marttin, E
    Schipper, NGM
    Verhoef, JC
    Merkus, FWHM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) : 13 - 38